APT Medical Inc. Share Price
Equities
688617
CNE100004C45
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 261.72 CNY | +0.40% |
|
+2.12% | +7.58% |
| 01-07 | Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 7-JAN-2026. | CI |
| 01-05 | Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on December 9, 2025. | CI |
| Capitalization | 36.91B 5.29B 4.55B 4.24B 3.94B 7.35B 478B 7.93B 48.74B 19.15B 228B 19.84B 19.44B 842B | P/E ratio 2025 * |
44.3x | P/E ratio 2026 * | 33.7x |
|---|---|---|---|---|---|
| Enterprise value | 35.82B 5.14B 4.41B 4.11B 3.82B 7.13B 464B 7.69B 47.31B 18.59B 222B 19.26B 18.86B 817B | EV / Sales 2025 * |
13.8x | EV / Sales 2026 * | 10.6x |
| Free-Float |
52.53% | Yield 2025 * |
0.57% | Yield 2026 * | 0.7% |
| 1 day | +0.40% | ||
| 1 week | +2.12% | ||
| Current month | +7.58% | ||
| 1 month | +9.87% | ||
| 3 months | -17.05% | ||
| 6 months | -11.28% | ||
| Current year | +7.58% |
| 1 week | 254.12 |  | 268.48 |
| 1 month | 235.14 | | 268.48 |
| Current year | 239.05 | | 268.48 |
| 1 year | 228.22 | | 337.2 |
| 3 years | 139.64 | | 337.2 |
| 5 years | 67.05 | | 337.2 |
| 10 years | 67.05 | | 337.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zheng Hui Cheng
CEO | Chief Executive Officer | 61 | 31/07/2016 |
Zhen Hua Dai
DFI | Director of Finance/CFO | 58 | 08/11/2019 |
Yu Chen Qiu
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Zheng Hui Cheng
CHM | Chairman | 61 | 30/04/2014 |
Yi Qing Xu
BRD | Director/Board Member | 63 | 30/04/2014 |
Zhen Hua Dai
BRD | Director/Board Member | 58 | 30/06/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +2.12% | +12.67% | +71.96% | 5.27B | |
| -0.01% | +0.01% | +0.01% | +67.18% | 12.57B | |
| -5.79% | -4.45% | +20.09% | +30.57% | 12.51B | |
| -1.82% | -3.11% | -21.99% | -16.19% | 7.1B | |
| +0.91% | +1.42% | +17.50% | -0.85% | 6.52B | |
| -3.11% | +7.67% | +22.24% | +34.33% | 6.22B | |
| -0.78% | -1.28% | +16.02% | +32.46% | 4.96B | |
| +0.05% | -.--% | +0.86% | +21.41% | 4.7B | |
| +0.49% | +5.86% | +31.69% | +11.92% | 1.96B | |
| +0.26% | +5.63% | +33.29% | -47.72% | 1.76B | |
| Average | -0.96% | +2.32% | +13.24% | +20.51% | 6.36B | |
| Weighted average by Cap. | -1.56% | +1.63% | +9.73% | +29.89% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.6B 373M 320M 299M 277M 518M 33.65B 558M 3.43B 1.35B 16.08B 1.4B 1.37B 59.31B | 3.35B 481M 413M 385M 358M 668M 43.4B 720M 4.43B 1.74B 20.74B 1.8B 1.77B 76.49B |
| Net income | 834M 120M 103M 95.76M 88.98M 166M 10.79B 179M 1.1B 433M 5.16B 448M 439M 19.02B | 1.1B 157M 135M 126M 117M 218M 14.18B 235M 1.45B 569M 6.78B 589M 577M 25B |
| Net Debt | -1.09B -156M -134M -125M -116M -217M -14.08B -234M -1.44B -564M -6.73B -585M -573M -24.82B | -1.38B -197M -170M -158M -147M -274M -17.82B -296M -1.82B -714M -8.51B -740M -725M -31.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 261.72 ¥ | +0.40% | 1,172,040 |
| 12/01/26 | 260.67 ¥ | -1.88% | 1,128,476 |
| 09/01/26 | 265.66 ¥ | +4.42% | 1,179,959 |
| 08/01/26 | 254.42 ¥ | -1.25% | 766,089 |
| 07/01/26 | 257.65 ¥ | -1.32% | 842,092 |
End-of-day quote Shanghai S.E., January 12, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688617 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition